Category Archive: 3) Swiss Markets and News

Main Author Investec
Investec
Investec is a distinctive Specialist Bank and Asset Manager. We provide a diverse range of financial products and services to a niche client base in three principal markets, the United Kingdom, South Africa and Australia, as well as certain other geographies. Investec’s strategic goals are motivated by the desire to develop an efficient and integrated business on an international scale through the active pursuit of clearly established core competencies in the group’s principal business areas.

Price cuts on 350 medicines in Switzerland

With the ever rising cost of of Swiss healthcare, the government has been hunting for savings. This week it announced that it has ordered price cuts on 350 medicines from 1 December 2023, reported RTS.

Read More »

Swiss finance minister wins 2023 obfuscation award

Every year, investigativ.ch, an association of investigative journalists, bestows an award on the public figure it deems to have exercised the lowest levels of transparency during the year.

Read More »

Swiss inflation returns in October

Consumer prices increased by 0.1% in October 2023, reported Switzerland’s Federal Statistical Office (FSO) this week.

Read More »

Credit Suisse wins London lawsuit over RMBS-linked notes

Credit Suisse on Friday won a lawsuit at London’s High Court over the sale of $100 million (CHF90.47 million) of notes linked to residential mortgage-backed securities.

Read More »

Swiss authorities reportedly mull new rules to prevent bank runs

Swiss authorities and lenders, including UBS, are discussing new measures to prevent bank runs after Credit Suisse’s last-ditch rescue earlier this year, four sources familiar with the matter told Reuters.

Read More »

UBS clash at Supreme Court tests whistleblower suit rules

The US Supreme Court considered reinstating a $900,000 (CHF810,000) jury verdict won by a fired UBS Group research strategist in a case that could make it easier for whistleblowers to win suits claiming retaliation under a federal investor-protection law.

Read More »

Proposal for budget Swiss health insurance

Last weekend, the PLR/FDP unveiled a plan to create a budget low cost health insurance option in Switzerland, reported RTS.

Read More »

Switzerland needs to be able to recharge 2.8 million vehicles

This week, the Swiss Federal Office of Energy (SFOE) published its predictions and ambitions for electric transport infrastructure.

Read More »

Switzerland to tax electric vehicles from 2024

Vehicles imported into Switzerland are subject to a 4% tax, with the exception of electric vehicles that attract none. This week, the government decided to end the exception from the beginning of next year.

Read More »

How to stop the commoditisation of container shipping

Don’t feel bad if MSC, the Mediterranean Shipping Company, is the biggest ocean-going carrier you have never heard of. It is meant to be that way. Its founder, Gianluigi Aponte, is a publicity-shy Italian billionaire, based in Switzerland, a country with no maritime borders and a culture of secrecy as deep as the ocean.

Read More »

Chinese companies choose Switzerland over US and UK to raise money overseas

Chinese companies are flocking to Switzerland to raise capital after being discouraged from listing in the US by geopolitical tensions and in Britain by tougher audit standards.

Read More »

Former top Credit Suisse shareholder Harris Associates sells out of bank

One of Credit Suisse’s longest-standing shareholders has sold its entire stake in the scandal-hit Swiss bank after losing patience with its strategy amid persistent losses and a client exodus.

Read More »

Swiss banks accused of hiding data behind secrecy laws

Swiss banking secrecy used to be the bane of foreign countries trying to catch tax cheats. Now it’s the turn of Swiss journalists and historians to cry foul of laws that can hinder their work.

Read More »

Switzerland sees surge in numbers of foreign workers

The number of new foreign workers moving to Switzerland on long-term contracts increased by a quarter last year compared to 2021, according to official statistics.

Read More »

Hefty fines against Swiss pharma giants lifted

An appeals court in France has overturned a record fine imposed by the French competition authority against the Swiss pharmaceutical companies Novartis and Roche.

Read More »

Glencore sees earnings reach new highs in 2022

Profits at Swiss mining and trading group Glencore last year were boosted by the explosion in commodity prices. Thanks to a more than threefold increase in net profit, the Zug-based giant wants to double its shareholders’ remuneration, in particular through a share buyback.

Read More »

Swiss government plans to strengthen ties with Asia-Pacific region

The Swiss government has for the first time adopted a regional strategy for the Asia-Pacific region for the period 2023-2026. The move takes into account the growing importance of the southeast Asia region and complements the government's China strategy, according to a government statement published on Wednesday.

Read More »

Six numbers that show why Credit Suisse has little leeway

Disappointing results leave no more room for accidents as the bank carries out restructuring. It has been a year since Axel Lehmann took over as chair of accident-prone Credit Suisse and about half that since Ulrich Körner became chief executive. But they have yet to stem the problems at Switzerland’s second-biggest bank, caused by a succession of historic scandals and mismanaged risk – from the blow-up of the Archegos family office to the...

Read More »

Quantum technology enjoys first commercial successes

Quantum physics is moving out of the lab and into the marketplace. Switzerland, a strong researcher in this field, doesn’t want to miss out and is launching its own quantum initiative. For now, though, it will have to make do without Europe.

Read More »

Swiss pharma industry wants to reduce dependence on Asia

The Swiss pharmaceutical industry should be less dependent on active ingredients from Asia, says the president of the industry umbrella organisation, pharmaSuisse. Martine Ruggli has called for new drug companies to be built in Europe.

Read More »